DK1368021T3 - Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom - Google Patents

Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom

Info

Publication number
DK1368021T3
DK1368021T3 DK02707850T DK02707850T DK1368021T3 DK 1368021 T3 DK1368021 T3 DK 1368021T3 DK 02707850 T DK02707850 T DK 02707850T DK 02707850 T DK02707850 T DK 02707850T DK 1368021 T3 DK1368021 T3 DK 1368021T3
Authority
DK
Denmark
Prior art keywords
sub
bipolar disorder
phenyl
alkyl
group
Prior art date
Application number
DK02707850T
Other languages
Danish (da)
English (en)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Yong Moon Choi
Robert Gordon
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1368021T3 publication Critical patent/DK1368021T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02707850T 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom DK1368021T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168001P 2001-02-27 2001-02-27
US10/081,606 US7122576B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
PCT/US2002/005425 WO2002067924A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number Publication Date
DK1368021T3 true DK1368021T3 (da) 2008-02-11

Family

ID=26765743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02707850T DK1368021T3 (da) 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom

Country Status (25)

Country Link
US (1) US7122576B2 (cg-RX-API-DMAC7.html)
EP (1) EP1368021B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276839B2 (cg-RX-API-DMAC7.html)
KR (1) KR20030074849A (cg-RX-API-DMAC7.html)
CN (1) CN1250214C (cg-RX-API-DMAC7.html)
AT (1) ATE378046T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002242226B2 (cg-RX-API-DMAC7.html)
BR (1) BR0207832A (cg-RX-API-DMAC7.html)
CA (1) CA2439292A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107199T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296641B6 (cg-RX-API-DMAC7.html)
DE (1) DE60223506T2 (cg-RX-API-DMAC7.html)
DK (1) DK1368021T3 (cg-RX-API-DMAC7.html)
ES (1) ES2295320T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303261A3 (cg-RX-API-DMAC7.html)
IL (2) IL157589A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007716A (cg-RX-API-DMAC7.html)
MY (1) MY133370A (cg-RX-API-DMAC7.html)
NO (1) NO20033799L (cg-RX-API-DMAC7.html)
NZ (1) NZ527989A (cg-RX-API-DMAC7.html)
PL (1) PL364640A1 (cg-RX-API-DMAC7.html)
PT (1) PT1368021E (cg-RX-API-DMAC7.html)
RS (1) RS50680B (cg-RX-API-DMAC7.html)
RU (1) RU2286147C2 (cg-RX-API-DMAC7.html)
WO (1) WO2002067924A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ553813A (en) * 2004-09-16 2010-09-30 Janssen Pharmaceutica Nv Use of 2-phenyl-1, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
JP4409630B2 (ja) * 2008-02-21 2010-02-03 田辺三菱製薬株式会社 経口投与用固形製剤
HRP20150196T1 (hr) 2008-07-16 2015-06-05 Richter Gedeon Nyrt. Farmaceutske formulacije s ligandima receptora dopamina
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
KR102635938B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CZ20032312A3 (cs) 2004-06-16
YU68003A (sh) 2006-08-17
RS50680B (sr) 2010-06-30
EP1368021A1 (en) 2003-12-10
CN1503666A (zh) 2004-06-09
NO20033799L (no) 2003-09-10
JP4276839B2 (ja) 2009-06-10
ATE378046T1 (de) 2007-11-15
WO2002067924A1 (en) 2002-09-06
CN1250214C (zh) 2006-04-12
ES2295320T3 (es) 2008-04-16
PT1368021E (pt) 2007-12-19
DE60223506D1 (de) 2007-12-27
CY1107199T1 (el) 2012-11-21
RU2286147C2 (ru) 2006-10-27
DE60223506T2 (de) 2008-09-18
HK1058762A1 (en) 2004-06-04
US20020193433A1 (en) 2002-12-19
BR0207832A (pt) 2004-06-22
MXPA03007716A (es) 2004-11-12
IL157589A0 (en) 2004-03-28
KR20030074849A (ko) 2003-09-19
RU2003128996A (ru) 2005-03-10
AU2002242226B2 (en) 2006-06-29
HUP0303261A2 (hu) 2004-01-28
HUP0303261A3 (en) 2012-07-30
CA2439292A1 (en) 2002-09-06
IL157589A (en) 2009-09-22
NZ527989A (en) 2005-12-23
PL364640A1 (en) 2004-12-13
CZ296641B6 (cs) 2006-05-17
US7122576B2 (en) 2006-10-17
JP2004525905A (ja) 2004-08-26
MY133370A (en) 2007-11-30
NO20033799D0 (no) 2003-08-26
EP1368021B1 (en) 2007-11-14

Similar Documents

Publication Publication Date Title
DK1368021T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom
MY157373A (en) Carbamate compounds for use in preventing or treating movement disorders
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
DK1408953T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
DK1305082T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte
RU2003128983A (ru) Производные карбаматов для предотвращения или лечения психотических нарушений
DK1408954T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neuropatisk smerte
WO2003007936A8 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain